Narwhal Capital Management Elevance Health, Inc. Transaction History

Narwhal Capital Management

$1.3 Billion
Q3 2025

A detailed history of Narwhal Capital Management transactions in Elevance Health, Inc. stock. As of the latest transaction made, Narwhal Capital Management holds 1,478 shares of ELV stock, worth $481,576. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,478

Previous 3,375 56.21%

Holding current value

$481,576

Previous $1.31 Million 63.64%

% of portfolio

0.04%

Previous 0.11%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	SELL	$274.66 - $395.76 $521,030 - $750,756	-1,897 Reduced 56.21%	1,478 $477,000
Q2 2025 Jul 23, 2025	SELL	$372.27 - $452.69 $111,681 - $135,807	-300 Reduced 8.16%	3,375 $1.31 Million
Q1 2025 Apr 22, 2025	SELL	$365.9 - $436.25 $219,540 - $261,750	-600 Reduced 14.04%	3,675 $1.6 Million
Q4 2024 Jan 21, 2025	SELL	$365.96 - $514.62 $237,874 - $334,503	-650 Reduced 13.2%	4,275 $1.58 Million
Q3 2024 Oct 22, 2024	SELL	$500.12 - $562.29 $1.63 Million - $1.83 Million	-3,253 Reduced 39.78%	4,925 $2.56 Million

Q2 2024 Aug 05, 2024	SELL	$497.49 - $547.8 $203,970 - $224,597	-410 Reduced 4.77%	8,178 $4.43 Million
Q1 2024 Apr 26, 2024	SELL	$464.61 - $519.96 $464,610 - $519,960	-1,000 Reduced 10.43%	8,588 $4.45 Million
Q3 2023 Oct 27, 2023	SELL	$414.13 - $475.93 $1,656 - $1,903	-4 Reduced 0.04%	9,588 $4.17 Million
Q2 2023 Aug 02, 2023	SELL	$436.33 - $496.2 $43,633 - $49,620	-100 Reduced 1.03%	9,592 $4.26 Million
Q4 2022 Jan 30, 2023	SELL	$465.23 - $546.77 $13,956 - $16,403	-30 Reduced 0.31%	9,692 $4.97 Million
Q2 2021 Jul 29, 2021	SELL	$352.19 - $401.9 $88,047 - $100,475	-250 Reduced 2.51%	9,722 $3.71 Million
Q1 2021 Apr 23, 2021	SELL	$287.7 - $371.31 $575,400 - $742,620	-2,000 Reduced 16.71%	9,972 $3.58 Million
Q4 2020 Feb 02, 2021	SELL	$270.17 - $333.15 $486,306 - $599,670	-1,800 Reduced 13.07%	11,972 $3.84 Million
Q3 2020 Oct 26, 2020	SELL	$245.73 - $284.63 $122,865 - $142,315	-500 Reduced 3.5%	13,772 $3.7 Million
Q1 2020 Apr 30, 2020	SELL	$174.68 - $307.74 $216,253 - $380,982	-1,238 Reduced 7.98%	14,272 $3.24 Million
Q3 2019 Oct 31, 2019	SELL	$237.69 - $310.48 $576,398 - $752,914	-2,425 Reduced 13.52%	15,510 $3.72 Million
Q2 2019 Jul 30, 2019	SELL	$236.25 - $293.76 $9,450 - $11,750	-40 Reduced 0.22%	17,935 $5.06 Million
Q1 2019 Apr 12, 2019	SELL	$248.42 - $317.42 $70,799 - $90,464	-285 Reduced 1.56%	17,975 $5.16 Million
Q4 2018 Jan 15, 2019	SELL	$249.0 - $296.25 $261,450 - $311,062	-1,050 Reduced 5.44%	18,260 $4.8 Million
Q1 2018 Apr 17, 2018	SELL	$215.63 - $258.19 $323,445 - $387,285	-1,500 Reduced 7.21%	19,310 $4.24 Million
Q4 2017 Jan 23, 2018	SELL	$183.76 - $234.96 $459,400 - $587,400	-2,500 Reduced 10.73%	20,810 $4.68 Million
Q3 2017 Oct 17, 2017	BUY	$181.44 - $197.43 $4.23 Million - $4.6 Million	23,310	23,310 $4.43 Million

Others Institutions Holding ELV

# of Institutions

1,797

Shares Held

199M

Call Options Held

2.37M

Put Options Held

2.14M

View Full List

About Elevance Health, Inc.

Ticker ELV
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 240,000,992
Market Cap $78.2B
Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....

More about ELV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Narwhal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Narwhal Capital Management with notifications on news.

Account

Narwhal Capital Management Elevance Health, Inc. Transaction History